| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0264-410X(91)90313-U |
| P698 | PubMed publication ID | 2008797 |
| P2093 | author name string | Dougan G | |
| Jones PW | |||
| Collins P | |||
| Hayward C | |||
| Chatfield SN | |||
| Mackensie N | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| P304 | page(s) | 29-34 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium | |
| P478 | volume | 9 |
| Q38896014 | Animal Models for Salmonellosis: Applications in Vaccine Research |
| Q37021492 | Attenuating gene expression (AGE) for vaccine development |
| Q46309797 | Auxotrophic, plasmid-cured Salmonella enterica serovar typhimurium for use as a live vaccine in calves |
| Q73318558 | Cattle immune responses to tetanus toxoid elicited by recombinant S. typhimurium vaccines or tetanus toxoid in alum or Freund's adjuvant |
| Q36951389 | Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis |
| Q33598287 | Characterization of an aromatic amino acid-dependent Listeria monocytogenes mutant: attenuation, persistence, and ability to induce protective immunity in mice. |
| Q40375337 | Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression |
| Q39822503 | Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene. |
| Q40149266 | Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers |
| Q34545910 | Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine |
| Q39512031 | Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves |
| Q50134874 | Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model |
| Q40409409 | Current perspectives in salmonellosis |
| Q35210803 | Delivery of Antigens by Recombinant a Virulent Salmonella Strains |
| Q36712633 | Genetic aspects of aromatic amino acid biosynthesis in Lactococcus lactis |
| Q42019490 | Immune response of pigs to parenteral vaccination with an aromatic-dependent mutant of Salmonella typhimurium |
| Q91700936 | Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity |
| Q33784947 | Live attenuated Salmonella: a paradigm of mucosal vaccines. |
| Q47571977 | Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin. |
| Q33938202 | Molecular basis of Salmonella-induced enteritis |
| Q39570610 | Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle. |
| Q36653379 | New technologies in developing recombinant attenuated Salmonella vaccine vectors |
| Q34524354 | Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid |
| Q50129092 | Passive immunisation of neonatal lambs via colostrum and milk of ewes previously immunised with live attenuated Salmonella typhimurium protects neonatal lambs from experimental salmonellosis |
| Q34935646 | Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host |
| Q36305113 | Recent developments in veterinary vaccinology |
| Q35433650 | Risks connected with the use of conventional and genetically engineered vaccines |
| Q45090216 | Salmonella DNA adenine methylase mutants elicit early and late onset protective immune responses in calves |
| Q34003465 | Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines |
| Q34007278 | Salmonella enterica serovar-host specificity does not correlate with the magnitude of intestinal invasion in sheep |
| Q35505997 | Studies of immunity and bacterial invasiveness in mice given a recombinant salmonella vector encoding murine interleukin-6. |
| Q40546686 | The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella |
| Q50133092 | The early dynamic response of the calf ileal epithelium to Salmonella typhimurium |
| Q35546681 | The spv genes on the Salmonella dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host. |
| Q43604617 | The virulence for gnotobiotic pigs of live attenuated vaccine strains of Salmonella enterica serovars Typhimurium and Enteritidis |
| Q50174904 | Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine |
| Q39373957 | Vaccination against Salmonella Infection: the Mucosal Way. |
| Q79147504 | Veterinary vaccines |
| Q40663159 | Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon |
Search more.